Achieve Life Sciences Receives Complete Response Letter from FDA for Cytisinicline NDA
NDA FilingCRLCytisiniclineNegative
AI Analysis
Summary
Achieve Life Sciences received a Complete Response Letter from the FDA for its Cytisinicline NDA, indicating the application was not approved and additional information or actions are required before resubmission.
Outcome Details
Complete Response Letter received from FDA
Importance:9/10
Sentiment:
-0.90
FDACRLNDAregulatory setbackspecialty pharmaceutical
Related Companies
Read the original article
Published by Drugs.com New Drug Applications on June 22, 2026 2:07 AM